European Nod For Roche’s Ocrevus Clouded By Patient Limitation

 
• By Kevin Grogan
Business Keyhole
Roche's MS drug Ocrevus is close to accessing the EU market • Source: Shutterstock

More from Neurological

More from Therapeutic Category